Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrow, L. A.
Right arrow Articles by Scott, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrow, L. A.
Right arrow Articles by Scott, A.
Related Collections
Right arrow Anxiety
Right arrow Depression
Right arrow Stress and Coping
Psychosomatic Medicine 62:746-750 (2000)
© 2000 American Psychosomatic Society


ORIGINAL ARTICLES

Increased Incidence of Anxiety and Depressive Disorders in Persons With Organic Solvent Exposure

Lisa A. Morrow, PhD, Christopher Gibson, PhD, George R. Bagovich, BA, Lawrence Stein, PhD, Ruth Condray, PhD and Allene Scott, MD

From the Department of Psychiatry (L.A.M., G.R.B., L.S., R.C.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Psychology (C.G.), Long Island University, Brooklyn, New York; and Armstrong Occupational Health Care (A.S.), Armstrong County Memorial Hospital, Kittanning, Pennsylvania.

Address reprint requests to: Lisa Morrow, PhD, Western Psychiatric Institute and Clinic, 3811 O’Hara St., Pittsburgh, PA 15213. Email: morrowla{at}msx.upmc.edu

OBJECTIVE: The purpose of this study was to determine whether the prevalence of current and past DSM-IV axis I psychiatric disorders is higher among persons with a history of exposure to organic solvents than among a demographically similar group of nonexposed control subjects.

METHODS: Thirty-eight solvent-exposed subjects and 39 nonexposed healthy control subjects were evaluated for axis I disorder with the Structured Clinical Interview for DSM-IV.

RESULTS: A significantly higher number of solvent-exposed subjects (71%) met criteria for current DSM-IV axis I disorder in comparison with control subjects (10%). The most prevalent diagnosis in exposed subjects was within the anxiety and mood clusters, with a high percentage (36%) of exposed subjects meeting criteria for a dual diagnosis of mood and anxiety disorder. There were no differences between the groups in past psychiatric disorders or current or past substance abuse or dependence.

CONCLUSIONS: The rates of past psychiatric disorders among solvent-exposed subjects are similar to those among normal control subjects, but the prevalence of current DSM-IV axis I psychiatric disorders is significantly higher among exposed subjects than among control subjects.

Key Words: organic solvents, • depression • anxiety, • psychiatric diagnoses • DSM-IV.

Abbreviations: DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, fourth edition; SCID = Structured Clinical Interview for DSM-IV.




This article has been cited by other articles:


Home page
International Social WorkHome page
G. T. Fernandes and M. G. Vaughn
Brazilian street children: Contextual influences in relation to substance misuse
International Social Work, September 1, 2008; 51(5): 669 - 681.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Psychosomatic Society